ARTICLE | Company News
Final NICE guidance recommends against Tarceva
June 28, 2011 11:57 PM UTC
The U.K.'s NICE issued final guidance recommending against Tarceva erlotinib from Roche (SIX:ROG; OTCQX:RHHBY) for the maintenance treatment of locally advanced or metastatic non-small cell lung cance...